Showing results (1-10 of 129) with videos related to
Sort By:
Pageof 13
Rheumatology International|January 29, 2000
Increased CD4+CD16+ and CD4+CD56+ T cell subsets in Behçet's diseaseE Eksioglu-Demiralp, H Direskeneli, T Ergun, et al.Clinical and Experimental Rheumatology|January 5, 2002
Neutrophil activation in Behçet's diseaseE Eksioglu-Demiralp, H Direskeneli, A Kibaroglu, et al.Clinical and Experimental Immunology|July 15, 1999
Oligoclonal T cell expansions in patients with Behçet's diseaseH Direskeneli, E Eksioglu-Demiralp, A Kibaroglu, et al.Clinical and Experimental Rheumatology|November 2, 2004
T and NK cell subset changes with microbial extracts and human HSP60-derived peptides in Behçet's diseaseA Kibaroglu, E Eksioglu-Demiralp, T Akoglu, et al.Clinical and Experimental Rheumatology|October 10, 2002
The effects of nitric oxide donors and inhibitors on neutrophil functions in Behçet's diseaseG Atalay, E Eksioglu-Demiralp, T Akoglu, et al.Clinical and Experimental Rheumatology|November 9, 2005
Oxidative burst response to monosodium urate crystals in patients with Behçet's syndromeF Gogus, I Fresko, Y Elbir, et al.Clinical Rheumatology|November 24, 2007
Thalidomide has both anti-inflammatory and regulatory effects in Behcet's diseaseH Direskeneli, T Ergun, S Yavuz, et al.Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology|December 22, 2004
Clinical and immunological effects of azithromycin in Behçet's diseaseG Mumcu, T Ergun, Y Elbir, et al.Lupus|July 16, 2008
CD8+CD28-, suppressive T cells in systemic lupus erythematosusA Tulunay, S Yavuz, H Direskeneli, et al.Immunology Letters|October 16, 2001
Human HSP 60 peptide responsive T cell lines are similarly present in both Behçet's disease patients and healthy controlsG Saruhan-Direskeneli, B Celet, E Eksioglu-Demiralp, et al.Pageof 13